For a hard copy of any report or document please contact the OHC
Pharmaceuticals - This page is the source for generic information addressing government drug policies, pharmacare and the pharmaceutical industry.
Action Resources
Message to members Pharmacies and Lobby Information
HTML PDF
(May 30, 2006)
MEDIA RELEASE:Ontario Health Coalition Supports Drug Legislation
It will contain escalating drug costs without harming patients
HTML PDF
(May 29, 2006)
Urgent Alert: Drug Bill (Bill 102) Update and Model Response HTML PDF
(May 28, 2006)
back to top of page
Pharmaceuticals Fact Sheets / Briefing Notes
Pharma Facts and Figures HTML PDF
(May 29, 2006)
Briefing Note
Pharmacare in the Public Interest MS WORD (August, 2004)
back to top of page
Reports on the Pharmaceutical Industry and Drug Polciies
author
title
link
description
date
N. Kalant, MD, PhD and I. Shrier, MD, PhD
Research Output of the Canadian Pharmaceutical Industry: Where Has All the R&D Gone?
PDF
HEALTHCARE POLICY Vol.1 No.4, 2006 [19]DISCUSSION AND DEBATE
April 2006
J. Lexchin, MD and N. Kalant, MD
BRIEF REGARDING BILL 102, AN ACT TO AMEND THE DRUG INTERCHANGEABILITY AND DISPENSING FEE ACT AND THE ONTARIO DRUG BENEFIT ACT
MS Word
Brief of the Medical Reform Group Presented to the Standing Committee on Social Policy of the Ontario Legislature on Monday, May 29th, 2006
May 29, 2006
Ontario Health Coalition
Ontario Health Coalition
Submission to the Standing Committee on Social Policy
on Bill 102, Transparent Drug System for Patients Act, 2006
PDF
In our view, the legislation is an important first step...the initiatives contained in this bill will not harm the health of patients and will work to control drug costs.
May 29, 2006
back to top of page
Media Releases on Pharmaceuticals and Drug Policy(2006)
MEDIA RELEASE:Ontario Health Coalition Supports Drug Legislation
It will contain escalating drug costs without harming patients
HTML PDF
(May 29, 2006)